Biotech Showcase 2026
12th – 14th January 2026
Hilton San Francisco Union Square in San Francisco, California
Connect with us at Biotech Showcase 2026Unlock Europe. Accelerate access.
At Sciensus, we help biotech innovators take the fastest route to patients in Europe. From clinical development through commercialisation, we offer integrated in-home clinical care, real-world insights and patient engagement solutions that remove operational blockers, reduce risk and accelerate market entry. As Europe continues to be a prime destination for biotech investment and growth, we partner with companies to turn early innovation into pan-European commercial success.
Meet our team at Biotech Showcase to explore how we can help you unlock Europe.
Meet the Sciensus team at Biotech Showcase 2026
Take part in our Europe-focused sessions designed for biotech innovators
From innovation to investment – unlocking access to Europe
Explore how biotech companies can strategically navigate the complex European landscape – from clinical development through commercialisation.
Tuesday 13th January 2:30-3:30pm – Imperial Ballroom
- De-risking European entry: How end-to-end commercialisation strategies reduce barriers and accelerate time to market across multiple jurisdictions
- Strategic partnerships that drive results: The role of integrated European partners in maximizing efficiency, market access, and investor confidence
- Scalable value creation: Turning early innovation into sustainable returns through coordinated, pan-European expansion strategies
Speakers:
- Christian Tucat, Chief Executive Officer, Sciensus
- Denise Scots-Knight, Executive Chairman, Scientific Founder, Clock.bio
- Maite Malet, Principal, Asabys Partners
- Ignacio Willats, Co-Founder & CCO, Mytos
Panel discussion
From innovation to investment – unlocking access to Europe
Explore how biotech companies can strategically navigate the complex European landscape – from clinical development through commercialisation.
Tuesday 13th January 2:30-3:30pm – Imperial Ballroom
- De-risking European entry: How end-to-end commercialisation strategies reduce barriers and accelerate time to market across multiple jurisdictions
- Strategic partnerships that drive results: The role of integrated European partners in maximizing efficiency, market access, and investor confidence
- Scalable value creation: Turning early innovation into sustainable returns through coordinated, pan-European expansion strategies
Speakers:
- Christian Tucat, Chief Executive Officer, Sciensus
- Denise Scots-Knight, Executive Chairman, Scientific Founder, Clock.bio
- Maite Malet, Principal, Asabys Partners
- Ignacio Willats, Co-Founder & CCO, Mytos
Fireside chat
Do you speak European? Keys to cutting through regional complexity to drive biotech success
Not all commercial routes to Europe are equal. This fireside chat will explore options beyond outsourcing or going it alone and will highlight the real operational blockers that slow European market entry.
Wednesday 14th January 09:30-09:50am – Imperial Ballroom
- Understanding the real barriers: The operational blockers that slow European market entry and how to address them strategically
- Beyond binary choices: Exploring commercial route options that go beyond traditional outsourcing or building everything in-house
- Learning from experience: Practical lessons from leaders who have successfully turned European complexity into commercial momentum and built investor confidence through integrated on-the-ground execution
Speakers:
- Alastair MacDonald, Head of Medical Affairs and Growth Strategy, Sciensus
- Grant Castor, Strategy & Operations at Sentynl
Expert-led insights to guide your European launch
Get a faster route into Europe
Request a meeting for a focused strategic conversation on your asset, where we’ll explore how you can accelerate access to Europe by using one integrated partner for end-to-end support.